Literature DB >> 22991014

Balance about balANZ.

Peter G Blake1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22991014      PMCID： PMC3524872          DOI： 10.3747/pdi.2012.00225

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  18 in total

Review 1.  In vitro biocompatibility performance of Physioneal.

Authors:  Catherine M Hoff
Journal:  Kidney Int Suppl       Date:  2003-12       Impact factor: 10.545

2.  Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.

Authors:  Jernej Pajek; Radoslav Kveder; Andrej Bren; Andrej Gucek; Maja Bucar; Andrej Skoberne; Jacek Waniewski; Bengt Lindholm
Journal:  Nephrol Dial Transplant       Date:  2008-12-09       Impact factor: 5.992

3.  Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.

Authors:  Sejoong Kim; Jieun Oh; Suhnggwon Kim; Wookyung Chung; Curie Ahn; Sung Gyun Kim; Kook-Hwan Oh
Journal:  Nephrol Dial Transplant       Date:  2009-03-03       Impact factor: 5.992

4.  Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.

Authors:  R A Mactier; T S Sprosen; R Gokal; P F Williams; M Lindbergh; R B Naik; U Wrege; K C Gröntoft; R Larsson; J Berglund; A P Tranaeus; D Faict
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

5.  A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group.

Authors:  A Tranaeus
Journal:  Perit Dial Int       Date:  2000 Sep-Oct       Impact factor: 1.756

6.  Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.

Authors:  Cheuk-Chun Szeto; Kai-Ming Chow; Christopher Wai-Kei Lam; Chi-Bon Leung; Bonnie Ching-Ha Kwan; Kwok-Yi Chung; Man-Ching Law; Philip Kam-Tao Li
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

7.  Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study.

Authors:  Philip Kam-Tao Li; Man Ching Law; Kai Ming Chow; Wing Ki Chan; Cheuk Chun Szeto; Yuk Lun Cheng; Teresa Yuk-Hwa Wong; Chi Bon Leung; Angela Yee-Moon Wang; Siu Fai Lui; Alex Wai-Yin Yu
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

8.  The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

Authors:  John D Williams; Nicholas Topley; Kathrine J Craig; Ruth K Mackenzie; Monika Pischetsrieder; Cristina Lage; Jutta Passlick-Deetjen
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

9.  Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function.

Authors:  S L S Fan; T Pile; S Punzalan; M J Raftery; M M Yaqoob
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

10.  The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.

Authors:  Hoon Young Choi; Dong Ki Kim; Tae Hee Lee; Sung Jin Moon; Seung Hyeok Han; Jung Eun Lee; Beom Seok Kim; Hyeong Cheon Park; Kyu Hun Choi; Sung Kyu Ha; Dae-Suk Han; Ho Yung Lee
Journal:  Perit Dial Int       Date:  2008 Mar-Apr       Impact factor: 1.756
View more
  1 in total

Review 1.  Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.

Authors:  Seychelle Yohanna; Ali M A Alkatheeri; Scott K Brimble; Brendan McCormick; Arthur Iansavitchous; Peter G Blake; Arsh K Jain
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.